Skip to search formSkip to main contentSkip to account menu

ecopipam

Known as: 5H-Benzo(d)naphth(2,1-b)azepin-12-ol, 11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-, trans-(-)- 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Antipsychotic AgentsBenzazepinesDopamine Antagonists
Ecopipam Hydrochloride

Narrower (1)

Sch 39166

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Update on the Treatment of Tics in Tourette Syndrome and Other Chronic Tic Disorders
Purpose of review This review presents a critical appraisal of current therapeutic strategies for tics in patients with Tourette… 
2019
2019
Ecopipam as a pharmacologic treatment of stuttering.
BACKGROUND Stuttering, also known as childhood-onset fluency disorder, is a chronic neurodevelopmental disorder that affects 1… 
2017
2017
Polypharmacological in Silico Bioactivity Profiling and Experimental Validation Uncovers Sedative-Hypnotic Effects of Approved and Experimental Drugs in Rat.
In this work, we describe the computational ("in silico") mode-of-action analysis of CNS-active drugs, which is taking both… 
Highly Cited
2015
Highly Cited
2015
The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists
2015
2015
The role of dopamine D 1 receptor transmission in effort-related choice behavior : Effects of D 1 agonists O O F
25 26 27 28 Q5 29 30 31 32 33 34 35 36 37 Article history: Received 31 January 2015 Received in revised form 5 May 2015 Accepted… 
2014
2014
A single-blind study of 'as-needed' ecopipam for gambling disorder.
BACKGROUND Gambling disorder is a disabling illness experienced by 1% to 3% of adults. Pharmacologic management of gambling… 
Review
2014
Review
2014
Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome.
PURPOSE OF REVIEW This update summarizes progress in understanding Tourette syndrome clinical characteristics, etiology, and… 
Highly Cited
2010
Highly Cited
2010
Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: Effects on locomotor activity
2004
2004
The dopamine D1 antagonist reduces ethanol reward for C57BL/6 mice.
BACKGROUND Dopamine D1 antagonist effects on behaviors related to obtaining and consuming ethanol remain unclear. The highly… 
2002
2002
Reaction of aziridinium ions with organometallic reagents: optimization of the key step of ecopipam synthesis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)